Výsledky vyhledávání - "Marso, S. P."

Akademický článek

Increase in interleukin-6 following arterial injury is related to insulin resistance, the −174G→C polymorphism and complex plaque morphology.

Autor: Marso, S. P.¹ smarso@saint-lukes.org, House, J. A.¹, Hopkins, P. J.²

Publikováno v: International Journal of Immunogenetics. Oct2006, Vol. 33 Issue 5, p347-354. 8p. 6 Charts, 1 Graph.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

LEADER 5 : prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Autor: Masmiquel, L., Leiter, L. A., Vidal, J., Bain, S., Petrie, J., Franek, E., Raz, I., Comlekci, A., Jacob, S., van Gaal, L., Baeres, F. M. M., Marso, S. P., Eriksson, M., LEADER Investigators

Publikováno v: Cardiovascular diabetology
Recercat. Dipósit de la Recerca de Catalunya
instname
Cardiovascular Diabetology
Dipòsit Digital de la UB
Universidad de Barcelona

Background: Epidemiological data on obesity are needed, particularly in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular (CV) risk. We used the baseline data of liraglutide effect and action in diabetes: evaluation of CV outcome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70aef5b0191ce1593cb23b13db5084c8
https://hdl.handle.net/10067/1322370151162165141

Zobrazit plný text záznamu

LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Autor: Moses, A. C., Derving Karsbøl, J., Mann, J. F. E., Bergenstal, R. M., Nauck, M. A., Marso, S. P., Hegedüs, L., Tuttle, R. M., Zinman, B., Daniels, G. H., Buse, J. B.

Publikováno v: Daniels, G H, Hegedüs, L, Marso, S P, Nauck, M A, Zinman, B, Bergenstal, R M, Mann, J F E, Derving Karsbøl, J, Moses, A C, Buse, J B, Tuttle, R M & LEADER trial investigators 2015, ' LEADER 2 : baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations ', Diabetes, Obesity and Metabolism, vol. 17, no. 5, pp. 477-486 . https://doi.org/10.1111/dom.12444

AIMS: To report preliminary data on baseline serum calcitonin concentrations and associated clinical characteristics in a global population with type 2 diabetes before liraglutide or placebo randomization.METHODS: The ongoing LEADER trial has enrolle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255a03fa30e6f8f87fb0efe9fa772be8
https://portal.findresearcher.sdu.dk/da/publications/6b126135-3229-45a0-91de-3007d2a84f89